Mazdutide is another dual-agonist in development that has shown competitive weight loss results in Chinese clinical trials
Implications for Clinicians: Understand the Evidence-Based Indian Semaglutide This Indian Phase III study demonstrates that the test semaglutide formulation provides glycemic and metabolic outcomes comparable to the international reference innovator product (Ozempic , Novo Nordisk) in patients with uncontrolled type 2 diabetes mellitus
Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for arandomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder
We offer a medical-grade framework, with emphasis on quality, safety, and individualized assessment
The UWLC-IM-3 is a three-probe control used to maintain the proper operating level when connected to a normally closed (NC) solenoid valve
Physicians must conduct thorough screenings that account for contraindications including a history of pancreatitis, thyroid cancer, and eating disorders